Concepedia

Yuli Wei

YW

Statistics

Publications

10

Citations

295

H-Index

10

Active since

2009

Affiliations

State Key Laboratory of Medicinal Chemical Biology(Current)

Nankai University

Tianjin International Joint Academy of Biomedicine

Tianjin Medical University

Tianjin First Center Hospital

Yuli Wei is an author at State Key Laboratory of Medicinal Chemical Biology specializing in pharmacology, pulmonary inflammation, and fibrosis.

Publications per year

2009–2023

10

Publications

10

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis

Ting Xiao, Yuli Wei, Mengqi Cui et al. · Phytomedicine · 2021 · 61 citations · Full text

, , +14

Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization

Xiaohe Li, Yuli Wei, Shimeng Li et al. · International Immunopharmacology · 2022 · 39 citations

, , +14

Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway

Songtao Gu, Jingjing Liang, Jianwei Zhang et al. · Molecules · 2023 · 38 citations · Full text

, , +15

Bergenin attenuates bleomycin‐induced pulmonary fibrosis in mice via inhibiting <scp>TGF</scp>‐β1 signaling pathway

Xiaohe Li, Yanhua Wang, Jingjing Liang et al. · Phytotherapy Research · 2021 · 32 citations

, , +15

Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway

Xiaohe Li, Ling Ma, Kai Huang et al. · International Journal of Molecular Sciences · 2021 · 29 citations · Full text

, , +14

1–5 of 10